The IMID Forum

Iain McInnes discusses patient-reported outcomes. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Member of the US Centers for Disease Control and a co-author of more than 100 publications. In this podcast, Prof Kevin Winthrop discusses the impact concomitant treatments have on HZ risk with Professor Maurizio Cutolo from the University of Genova. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Professor McInnes presents the most notable papers of 2019. You can find detailed summaries of the papers highlighted on http://www.cytokinesignalling.com/en/publications/review-article/511/

Professor McInnes presents the monthly podcast reviewing a paper by Professor Ying‐Chou Chen and another paper by Professor Genovese.

Professor McInnes presents the monthly podcast reviewing a paper by Dr Katie Bechman and another paper by Professor Lee YH.

In this edition of Congress Author Podcasts, recorded at ACR 2019, the latest data from the FINCH studies are presented by Professors Taylor, Westhovens and Winthrop, in addition to filgotinib safety data from a phase 2 Psoriatic Arthritis trial, presented by Professor Coates.

In this edition, recorded at ACR 2019, real-world tofacitinib safety data is presented by Professor Kremer and the impact of baricitinib and tofacitinib on pain is analysed by Professors Taylor and Dougados

In this edition experts, including Professor Smolen and Professor McInnes, present the latest data for the recently approved JAK inhibitor, upadacitinib. The presentations include: data from the SELECT trials, safety analyses, switching from TNF inhibitors, and the mode of action of upadacitinib.

Professor Calabrese introduces highlights from Day 4 of ACR 2019

Professor Calabrese introduces highlights from Day 3 of ACR 2019

Professor Calabrese presents highlights from Day 2 of ACR 2019

Professor Kevin Winthrop introduces the key abstracts from Day 1 at ACR 2019

Professor McInnes presents the monthly podcast reviewing a paper by Professor Bruno Fautrel and another paper by Professor Christina Charles-Schoeman.

Prof McInnes presents the monthly podcast reviewing a paper he authored along with colleagues and another paper by Dr Mori Shunsuke.

Professor Nash Interviews Professor Fleischmann from the University of Texas Southwester Medical Center, about his two recently published papers on upadacitinib.

Professor Nash Interviews Professor Leonard Calabrese from the RJ Fasenmyer Center for clinical Immunology, about his paper examining the live zoster vaccine in patients treated with tofacitinib monotherapy, tofacitinib with MTX and adalimumab with MTX.

Professor Iain McInnes joined by Professor Johannes Bijlsma, discusses the changes required to educate the next generation of rheumatologists, highlighting the benefits of online educational courses and the importance of quality amid a plethora of information.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Fleischmann and Professor Takeuchi.

Professor Nash interviews Dr Roland Grenningloh from the EMD Serono Research and Development Institute, about his paper describing the PK modelling of the novel Bruton’s tyrosine kinase (BTK) inhibitor, evobrutinib, in disease models for RA and lupus.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Tanaka and Professor Calabrese.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Josef Smolen and Professor Wenhui Xie, respectively.

Professor Nash interviews Professor Kevin Winthrop from Oregon Health Sciences University, Portland or USA, about his paper investigating pneumococcal and tetanus vaccine responses in patients with RA receiving baricitinib treatment.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Winthrop K and Professor Wollenhaupt J, respectively

Professor Nash interviews Professor Bernard Combe from the University of Montpellier, France, about a letter investigating the safety of baricitinib treatment in patients with select comorbidities.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Combe B and Dr. Zhang Z, respectively

Professor Nash interviews Professor Tsutomu Takeuchi from Keio University School of Medicine, about the paper looking at safety profile of baricitinib in Japanese patients.

Professor McInnes reviews key abstract from ACR 2018, relating to pain and JAK inhibitors.

Prof McInnes presents the monthly podcast reviewing two papers from Dr. Chengfeng Qiu and Dr. Camean-Castillo, respectively

Professor Nash interviews Professor Peter Taylor from the University of Oxford, about his paper looking at effects of baricitinib on lymphocyte subsets in rheumatoid arthritis

Prof McInnes presents the monthly podcast reviewing two papers from Prof Peter Taylor and van der Heijde, respectively

Prof McInnes presents the monthly podcast reviewing two papers from Prof Tanaka and Kivitz, respectively

Prof McInnes presents the monthly podcast reviewing two papers from Head of Clinical Pharmacology at Galapagos, Florence Namour, and Prof van Vollenhoven

Professor Nash interviews Florence Namour from Galapagos about her recent paper: Influence of Age and Renal Impairment on the Steady State Pharmacokinetics of Filgotinib, a Selective JAK1 Inhibitor

Prof McInnes presents the monthly podcast reviewing two papers from Prof van Vollenhoven and Prof Curtis

Professor Nash interviews Professor Curtis about his recent paper: Herpes zoster in Tofacitinib: Risk is Further Increased with Glucocorticoids but not Methotrexate

Dr Tracy Lovatt, Scientific Director for CESAS Medical, interviews ACR poster authors; Dr Litman, Dr Dominguez-Casas, Professor Fleischmann, Dr Mirza, Professor Taylor, Professor Kivitz and Dr Kunder.

Prof McInnes presents the monthly podcast reviewing two papers from Prof Takeuchi and Prof Smolen

Prof McInnes presents the monthly podcast reviewing two papers from Prof Kremer and Prof Taylor

Professor Nash interviews Professor Emery about his recent paper: Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review

Prof McInnes presents the monthly podcast reviewing two papers which looked at the safety profiles of tocilizumab and sarilumab, authored by Prof Kaneko and Prof Genovese, respectively

Professor Nash interviews Professor Atzeni about her recent paper: Adverse Events, Clinical Considerations and Management Recommendations in Rheumatoid Arthritis Patients Treated with JAK Inhibitors

Prof McInnes presents the monthly podcast reviewing two upadacitinib phase 3 papers from Prof Burmester and Prof Genovese

Prof McInnes presents the monthly podcast reviewing papers from Prof Strand and Prof van der Heijde

Professor Nash interviews Professor Strand about her recent paper: Evaluation of Disease Activity in Patients with Rheumatoid Arthritis Treated with Tofacitinib by RAPID3: Post Hoc Analyses from Two Phase 3 Trials

Prof McInnes presents the monthly podcast reviewing papers from Prof van Vollenhoven and Prof Strand

Prof McInnes presents the CSF monthly podcast reviewing papers from Prof Genovese, Prof Machado, Prof Ren and Prof Uttley

Prof McInnes presents the CSF monthly podcast reviewing papers from Prof Genovese, Prof Fleischmann and Prof Cohen

Prof Nash interviews Prof Fleischmann about his recent paper: Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis

Prof Bijlsma interviews Xavier Teitsma about his recent paper: Radiographic joint damage in early rheumatoid arthritis patients: comparing tocilizumab and methotrexate-based treat-to-target strategies

Prof McInnes presents the CSF monthly podcast reviewing papers from Prof Li, Xavier Teitsma and Prof Edwards